HK1104782A1 - Use of the salts, addition compounds and complex compounds of guanidinoacetic acid - Google Patents

Use of the salts, addition compounds and complex compounds of guanidinoacetic acid

Info

Publication number
HK1104782A1
HK1104782A1 HK07113011A HK07113011A HK1104782A1 HK 1104782 A1 HK1104782 A1 HK 1104782A1 HK 07113011 A HK07113011 A HK 07113011A HK 07113011 A HK07113011 A HK 07113011A HK 1104782 A1 HK1104782 A1 HK 1104782A1
Authority
HK
Hong Kong
Prior art keywords
acid
salts
compounds
carnitine
complex compounds
Prior art date
Application number
HK07113011A
Other languages
English (en)
Inventor
Gastner Thomas
Krimmer Hans-Peter
Original Assignee
Alzchem Trostberg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alzchem Trostberg Gmbh filed Critical Alzchem Trostberg Gmbh
Publication of HK1104782A1 publication Critical patent/HK1104782A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK07113011A 2005-03-04 2007-11-29 Use of the salts, addition compounds and complex compounds of guanidinoacetic acid HK1104782A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005009990A DE102005009990A1 (de) 2005-03-04 2005-03-04 Salze, Anlagerungs- und Komplexverbindungen der Guanidinoessigsäure
PCT/EP2006/001908 WO2006092298A1 (de) 2005-03-04 2006-03-02 Salze, anlagerungs- und komplexverbindungen der guanidinoessigsäure

Publications (1)

Publication Number Publication Date
HK1104782A1 true HK1104782A1 (en) 2008-01-25

Family

ID=36129675

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07113011A HK1104782A1 (en) 2005-03-04 2007-11-29 Use of the salts, addition compounds and complex compounds of guanidinoacetic acid

Country Status (18)

Country Link
US (1) US8153685B2 (zh)
EP (1) EP1853248B1 (zh)
JP (1) JP4928473B2 (zh)
CN (1) CN101132786B (zh)
AT (1) ATE412410T1 (zh)
AU (1) AU2006220005B2 (zh)
BR (1) BRPI0609372B1 (zh)
CA (1) CA2600890C (zh)
DE (2) DE102005009990A1 (zh)
DK (1) DK1853248T3 (zh)
ES (1) ES2313616T3 (zh)
HK (1) HK1104782A1 (zh)
PL (1) PL1853248T3 (zh)
PT (1) PT1853248E (zh)
RU (1) RU2402921C2 (zh)
UA (1) UA97090C2 (zh)
WO (1) WO2006092298A1 (zh)
ZA (1) ZA200706998B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2416355T3 (es) * 2005-08-02 2013-07-31 Alzchem Ag Formulación líquida a base de un componente de ácido guanidinoacético
DE102006009373A1 (de) * 2006-03-01 2007-09-06 Degussa Gmbh Fertigfutter für Haustiere
DE102007004781A1 (de) 2007-01-31 2008-08-07 Alzchem Trostberg Gmbh Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels
DE102007034102A1 (de) * 2007-07-21 2009-01-22 Alzchem Trostberg Gmbh Abriebfeste und rieselfähige Glycocyamin-haltige Formlinge und Verfahren zu deren Herstellung
DE102007062288A1 (de) * 2007-12-21 2009-06-25 Alzchem Trostberg Gmbh Kreatin-Zubereitung und Verfahren zu deren Herstellung
US7874536B2 (en) * 2008-09-26 2011-01-25 Groover David O Angle ceiling hanger or bracket
EP2519114A1 (en) 2009-12-29 2012-11-07 Hill's Pet Nutrition, Inc. Compositions including pyruvate for companion animals and methods of use thereof
CN101912044A (zh) * 2010-08-13 2010-12-15 青岛天通生物科技有限公司 促肌肉生成的组合物及其制备方法
CN104605161B (zh) * 2015-01-23 2018-02-27 长沙兴嘉生物工程股份有限公司 胍基乙酸配合物的制备方法及其应用
DE102019118898A1 (de) * 2019-07-12 2021-01-14 Alzchem Trostberg Gmbh Konzentrat zur Herstellung einer Tränklösung
DE102019120249A1 (de) * 2019-07-26 2021-01-28 Alzchem Trostberg Gmbh Verwendung einer Zusammensetzung zur Reduzierung der Feuchtigkeit und des Stickstoffgehalts in Faeces von Geflügel
DE102019120246A1 (de) 2019-07-26 2021-01-28 Alzchem Trostberg Gmbh Verfahren zur Fütterung von Geflügel
DE102019120244A1 (de) * 2019-07-26 2021-01-28 Alzchem Trostberg Gmbh Verwendung einer Zusammensetzung zur Verminderung des Federverlustes von Vögeln
DE102019121526A1 (de) 2019-08-09 2021-02-11 Alzchem Trostberg Gmbh Konzentrat zur Herstellung von Tränklösungen (II)
DE102021126581A1 (de) 2021-10-13 2023-04-13 Alzchem Trostberg Gmbh Verwendung eines Futtermitteladditives in energiearmen Futter für Schweine
CN114751845B (zh) * 2022-06-13 2022-09-20 北京君德同创生物技术股份有限公司 一种易溶的胍基乙酸络合物的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195199A (en) * 1966-11-25 1970-06-17 Horlicks Pharmaceuticals Ltd Improvements in Compositions comprising Insulin.
GB1195200A (en) * 1967-02-07 1970-06-17 Horlicks Pharmaceuticals Ltd Pharmaceutical Compositions.
JPS61231996A (ja) * 1985-04-04 1986-10-16 Kikkoman Corp グアニジノ酢酸分解酵素の安定化法
IT1237519B (it) * 1989-11-27 1993-06-08 Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
JPH09202710A (ja) * 1995-11-20 1997-08-05 Kao Corp しわ改善剤
US5939078A (en) 1995-11-20 1999-08-17 Kao Corporation Wrinkle-care product
JP3708229B2 (ja) * 1996-07-04 2005-10-19 花王株式会社 毛髪処理剤組成物
US6242491B1 (en) 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6855727B2 (en) * 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
AU2003247224A1 (en) 2002-06-19 2004-01-06 N.V. Nutricia Nutritional or pharmaceutical compositions for increasing the creatine response of organisms
DE502005002355D1 (de) * 2004-06-09 2008-02-07 Evonik Degussa Gmbh Guanidinoessigsäure als futtermittelzusatz

Also Published As

Publication number Publication date
DE102005009990A1 (de) 2006-09-07
ES2313616T3 (es) 2009-03-01
RU2007136761A (ru) 2009-04-10
BRPI0609372B1 (pt) 2020-09-08
US20080161387A1 (en) 2008-07-03
DE502006001941D1 (de) 2008-12-11
CN101132786A (zh) 2008-02-27
JP4928473B2 (ja) 2012-05-09
EP1853248B1 (de) 2008-10-29
EP1853248A1 (de) 2007-11-14
WO2006092298A1 (de) 2006-09-08
ZA200706998B (en) 2008-11-26
CN101132786B (zh) 2011-04-13
RU2402921C2 (ru) 2010-11-10
BRPI0609372A2 (pt) 2010-03-30
AU2006220005A1 (en) 2006-09-08
DK1853248T3 (da) 2009-02-16
CA2600890C (en) 2014-07-15
ATE412410T1 (de) 2008-11-15
CA2600890A1 (en) 2006-09-08
PT1853248E (pt) 2009-02-09
PL1853248T3 (pl) 2009-01-30
AU2006220005B2 (en) 2011-07-21
US8153685B2 (en) 2012-04-10
UA97090C2 (ru) 2012-01-10
JP2008531029A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
ZA200706998B (en) Salts, addition compounds and complex compounds of guanidinoacetic acid
WO2011107653A8 (en) Use of levodopa, carbidopa and entacapone for treating parkinson's disease
MX2013012231A (es) Composiciones nutricionales que tienen a-hica y a-cetoglutarato y metodos para utilizar las mismas.
ATE469674T1 (de) 5-aminolävulinsäure-derivate zur behandlung von akne
EA200970287A1 (ru) Способы, соединения, композиции и носители, подходящие для доставки 3-амино-1-пропансульфоновой кислоты
EP3192506A3 (en) Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative or 5-aminolevulinic acid as active ingredient
NZ610911A (en) Continuous administration of l-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions for same
MX2007013623A (es) Preparacion externa para la piel.
SG162744A1 (en) Stable active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
ZA201005615B (en) Pharmaceutical compositions of entacapone,levodopa and carbidopa with improved bioavailability
UA108996C2 (en) BIOLOGICALLY ACTIVE SUPPLEMENT TO FOOD FOR PREVENTION OF OSTEOPOROSIS DISEASES
TW200621732A (en) Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
CL2013003057A1 (es) Composicion farmaceutica de aerosol en forma de solución acuosa para nebulización que comprende iloprost, que proporciona una dosis unica eficaz aerolizada para inhalacion de bolo en un periodo de menos de 2 minutos; kit farmacéutio, util en el tratamiento de hipertension arterial pulmonar.
EP1747786A3 (en) Natural product in cream with anti-vitiligo therapeutic properties
WO2010022201A3 (en) Folinic acid derivatives for promoting bone growth
MX2009013937A (es) Nuevo uso de compuestos quimicos farmacologicamente activos conocidos.
JP2010508249A5 (zh)
ATE487390T1 (de) Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs
BR112013031496A2 (pt) composição de aminoácidos
SMT201300112B (it) Sale citrato di 9E-15-(2-pirrolidin-1-il-etossi)-7,12,25-triossa-19,21,24-triaza-tetracicloÄ18.3.1.1(2,5).1(14,18)Üesacos a-1(24),2,4,9,14,16,18(26),20,22-nonaene
WO2010072209A3 (de) Nahrungsergänzungsmittel auf der basis von pantothensäure
TR200806646A2 (tr) Entakapon, levodopa ve karbidoba içeren farmasötik kombinasyonlar
MY160005A (en) 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt
FR2984735B1 (fr) Composition hydratante
WO2014006571A3 (en) Extended-release pharmaceutical dosage forms of carbidopa and levodopa and processes of preparation thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150302